Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis

Clinical Pharmacology and Therapeutics
L S OlanoffE C Conradi

Abstract

The influence of a high-protein meal as compared to fasting on the disposition of simultaneous intravenous and oral doses of propranolol, as well as on indocyanine green clearance, was examined in six normal subjects. The intravenous dose (0.1 mg/kg) was unlabeled propranolol and the oral dose (80 mg) was a stereospecifically deuterium-labeled pseudoracemate of propranolol. Systemic clearance of propranolol increased 38%, from 1005 +/- 57 to 1384 +/- 115 ml/min (mean +/- SE; P less than 0.05) as a result of the meal, with no change in t1/2 or apparent volume of distribution. A 12% decrease in oral clearance occurred with the meal but was not statistically significant (3717 +/- 185 ml/min, fasting; 3245 +/- 498 after meal), whereas bioavailability increased 67% (27.2% +/- 1.7% fasting; 45.5% +/- 4.3% after meal; P less than 0.01). Estimated hepatic blood flow, as measured by indocyanine green clearance, rose 34% 60 minutes after the meal (1719 +/- 155 ml/min fasting; 2304 +/- 218 ml/min after meal; P less than 0.02). A difference was observed in the oral clearance of the propranolol enantiomers in the fasting state, but this difference was unaffected by the meal. These alterations in propranolol disposition, as the result of a h...Continue Reading

Citations

Oct 1, 1995·Biopharmaceutics & Drug Disposition·J M PowerA J McLean
Jun 14, 2008·Pharmaceutical Research·Vangelis KaralisVinod P Shah
Jun 1, 1992·British Journal of Clinical Pharmacology·J SahaiD W Cameron
Nov 1, 1991·British Journal of Clinical Pharmacology·B Lemmer, G Nold
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·N CastroH Jung
Oct 27, 2007·Journal of Clinical Pharmacology·Themba T NdoviCraig W Hendrix
Apr 8, 2017·Clinical Pharmacology in Drug Development·Jing-He Yan
Jul 1, 1993·Journal of Clinical Pharmacology·D LalkaC L Cronenberger
Jan 1, 1993·European Journal of Drug Metabolism and Pharmacokinetics·B Oosterhuis, J H Jonkman
Jan 1, 1990·European Journal of Clinical Pharmacology·H LiedholmA Melander
Mar 1, 1989·Journal of Clinical Pharmacology·F KellerG Offermann
Apr 21, 2012·British Journal of Clinical Pharmacology·Laurent B NicolasJasper Dingemanse
Apr 14, 2017·CNS Drugs·Peer Tfelt-HansenJacob Tfelt-Hansen
Mar 28, 2001·Journal of Clinical Pharmacology·B OlssonH Arnberg
Jun 12, 2012·Expert Opinion on Drug Metabolism & Toxicology·Vangelis Karalis, Panos Macheras
Jul 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Jan 17, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jennifer K MacCormackKeely A Muscatell
Jun 12, 2021·Critical Care : the Official Journal of the Critical Care Forum·Josée BouchardUNKNOWN EXTRIP workgroup
Aug 2, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·E MehuysC Vervaet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved